Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...

VU grad wins Fulbright grant Micah Koppang, a 2025 Valparaiso University graduate, has been selected for a Fulbright scholarship. Koppang, a Spanish major with a minor in political science who ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...